Discounted Cash Flow
Loandepot, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $1.3b | $0 | $-1.5b | 0.0% | — |
| 2020 | $4.3b (222.5%) | $0 | $-2.1b (-36.7%) | 0.0% | — |
| 2021 | $3.7b (-13.6%) | $113.5m | $113.5m (105.5%) | 3.0% | $4.79 |
| 2022 | $1.3b (-66.3%) | $-273.0m (-340.5%) | $-273.0m (-340.5%) | -21.7% (-813.3%) | $-3.91 (-181.6%) |
| 2023 | $974.0m (-22.4%) | $-110.1m (59.7%) | $-194.8m (28.6%) | -11.3% (48.0%) | $-1.35 (65.6%) |
| 2024 | $1.1b (8.9%) | $-98.3m (10.7%) | $-891.8m (-357.7%) | -9.3% (18.0%) | $-0.54 (59.6%) |
| 2025 | $1.2b (12.2%) | $-62.6m (36.3%) | $-62.6m (93.0%) | -5.3% (43.2%) | $-0.25 (53.2%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.